Fundraising Fox
Auransa
11 employees on LinkedIn · 4 known investors
Find your way into Auransa
Each arrow is one introduction. Sign up to fill in the first one.
233 people can intro you to Pek
Ask David Lane to introduce you to Pek Lum
You →David · together at Auransa Inc. →Pek
Sign up to find every way you can get introduced to Auransa
- Your email: who you already know at Auransa, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Auransa team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Auransa is a clinical-stage, AI-native biopharma company that analyzes large human disease datasets to discover and develop novel cancer therapies. It works collaboratively with pharmaceutical companies and academic institutions to advance its drug discovery programs.
Founders & leadership
PL
Pek LumCo-Founder & CEOPek Lum was an early employee at Rosetta, a genomics technology company acquired by Merck, where he worked on integrating data science into drug discovery. He is now co-founder and CEO of Auransa, a clinical-stage biopharma company developing AI-powered cancer therapies.
Investors · 4
Frequently asked questions
- What does Auransa do?
- Auransa is a clinical-stage, AI-native biopharma company that analyzes large human disease datasets to discover and develop novel cancer therapies. It works collaboratively with pharmaceutical companies and academic institutions to advance its drug discovery programs.
- Who founded Auransa?
- Auransa was founded by Pek Lum.
- Who are Auransa's investors?
- Auransa's investors include 11.2 Capital, DCVC (Data Collective), Harmonix Fund, Lux Capital.